Osteopontin functionalization of hydroxyapatite nanoparticles in a PDLLA matrix promotes bone formation

Journal of Biomedical Materials Research - Part A

Volumn 99 A, Issue 1, 2011, Pages 94-101

  Jensen, T ^a,b   Baas, J ^a   Dolathshahi Pirouz, A ^b   Jacobsen, T ^a   Singh, G ^b   Nygaard, J V ^b   Foss, M ^b   Bechtold, J ^a   Bunger C ^a   Besenbacher, F ^b   Soballe K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

biocompatibility; composite; hydroxyapatite; osteointegration; osteopontin

Indexed keywords

BONE FORMATION; COMPOSITE; FUNCTIONALIZATIONS; FUNCTIONALIZED; MATRIX; OSTEOCONDUCTIVE; OSTEOINTEGRATION; OSTEOPONTIN; REFERENCE CONTROL; TISSUE RESPONSE;

BIOCOMPATIBILITY; BONE; COATINGS; COMPOSITE COATINGS; HYDROXYAPATITE; NANOPARTICLES; TISSUE;

APATITE;

HYDROXYAPATITE; NANOPARTICLE; OSTEOPONTIN; POLYLACTIC ACID; TITANIUM;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; COMPOSITE MATERIAL; CONTROLLED STUDY; DOG; IMPLANT; MATERIAL COATING; NONHUMAN; OSSIFICATION;

ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; COATED MATERIALS, BIOCOMPATIBLE; DOGS; DURAPATITE; LACTIC ACID; MATERIALS TESTING; NANOPARTICLES; OSTEOGENESIS; OSTEOPONTIN; POLYMERS;

EID: 80051877106     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33166     Document Type: Article

References (40)

1. Annual report 2007. Danish Hip Arthroplasty Registry. 2007.
2. Karrholm J, Herberts P, Hultmark P, Malchau H, Nivbrant B, Thanner J,. Radiostereometry of hip prostheses. Review of methodology and clinical results. Clin Orthop Relat Res 1997; 344: 94-110. (Pubitemid 27490640)
3. Ryd L, Albrektsson BE, Carlsson L, Dansgard F, Herberts P, Lindstrand A, Regner L, Toksvig-Larsen S,. Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses. J Bone Joint Surg Br 1995; 77: 377-383.
4. Franzen A, Heinegard D,. Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 1985; 232: 715-724. (Pubitemid 16207308)
5. McKee MD, Nanci A,. Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech 1996; 33: 141-164. (Pubitemid 26021996)
6. Duvall CL, Taylor WR, Weiss D, Wojtowicz AM, Guldberg RE,. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res. 2007; 22: 286-297. (Pubitemid 46167799)
7. Franzen A, Hultenby K, Reinholt FP, Onnerfjord P, Heinegard D,. Altered osteoclast development and function in osteopontin deficient mice. J Orthop Res 2008; 26: 721-728.
8. Ishijima M, Rittling SR, Yamashita T, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M,. Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 2001; 193: 399-404. (Pubitemid 32524523)
9. Yoshitake H, Rittling SR, Denhardt DT, Noda M,. Osteopontin- deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 1999; 96: 8156-8160. (Pubitemid 29328424)
10. Asou Y, Rittling SR, Yoshitake H, Tsuji K, Shinomiya K, Nifuji A, Denhardt DT, Noda M,. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 2001; 142: 1325-1332. (Pubitemid 32202845)
11. Liu L, Chen G, Chao T, Ratner BD, Sage EH, Jiang S,. Reduced foreign body reaction to implanted biomaterials by surface treatment with oriented osteopontin. J Biomater Sci Polym Ed 2008; 19: 821-835. (Pubitemid 351820785)
12. Tsai AT, Rice J, Scatena M, Liaw L, Ratner BD, Giachelli CM,. The role of osteopontin in foreign body giant cell formation. Biomaterials 2005; 26: 5835-5843. (Pubitemid 40803458)
13. Bernards MT, Qin C, Jiang S,. MC3T3-E1 cell adhesion to hydroxyapatite with adsorbed bone sialoprotein, bone osteopontin, and bovine serum albumin. Colloids Surf B Biointerface 2008; 64: 236-247.
14. Lee YJ, Park SJ, Lee WK, Ko JS, Kim HM,. MG63 osteoblastic cell adhesion to the hydrophobic surface precoated with recombinant osteopontin fragments. Biomaterials 2003; 24: 1059-1066. (Pubitemid 36020394)
15. Liu L, Chen S, Giachelli CM, Ratner BD, Jiang S,. Controlling osteopontin orientation on surfaces to modulate endothelial cell adhesion. J Biomed Mater Res A 2005; 74: 23-31. (Pubitemid 41099247)
16. Liu L, Qin C, Butler WT, Ratner BD, Jiang S,. Controlling the orientation of bone osteopontin via its specific binding with collagen I to modulate osteoblast adhesion. J Biomed Mater Res A 2007; 80: 102-110. (Pubitemid 44913338)
17. Gordjestani M, Dermaut L, De Ridder L, De Waele P, De Leersnijder W, Bosman F,. Osteopontin and bone metabolism in healing cranial defects in rabbits. Int J Oral Maxillofac Surg 2006; 35: 1127-1132. (Pubitemid 44718378)
18. Jensen T, Dolatshahi-Pirouz A, Foss M, Baas J, Lovmand J, Duch M, Pedersen FS, Kassem M, Bunger C, Soballe K, et al. Interaction of human mesenchymal stem cells with osteopontin coated hydroxyapatite surfaces. Colloids Surf B Biointerfaces 2010; 75: 186-193.
19. Hasegawa S, Neo M, Tamura J, Fujibayashi S, Takemoto M, Shikinami Y, Okazaki K, Nakamura T,. In vivo evaluation of a porous hydroxyapatite/poly-DL- lactide composite for bone tissue engineering. J Biomed Mater Res A 2007; 81: 930-938. (Pubitemid 46835088)
20. Hasegawa S, Tamura J, Neo M, Goto K, Shikinami Y, Saito M, Kita M, Nakamura T,. In vivo evaluation of a porous hydroxyapatite/poly-DL-lactide composite for use as a bone substitute. J Biomed Mater Res A 2005; 75: 567-579. (Pubitemid 47233440)
21. Kim SS, Sun Park M, Jeon O, Yong Choi C, Kim BS,. Poly(lactide-co- glycolide)/hydroxyapatite composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 1399-1409. (Pubitemid 41739565)
22. Heo SJ, Kim SE, Wei J, Hyun YT, Yun HS, Kim DH, Shin JW,. Fabrication and characterization of novel nano- and micro-HA/PCL composite scaffolds using a modified rapid prototyping process. J Biomed Mater Res A 2008; 89: 108-116.
23. Ducheyne P, Qiu Q,. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999; 20: 2287-2303.
24. Smith TS,. Characterization of Porous Coatings. In:, Lee SM, editor. Advances in Biomaterials. Boca Raton, FL: CRC Press; 1987.
25. Jensen T, Jakobsen T, Baas J, Nygaard JV, Dolatshahi-Pirouz A, Hovgaard MB, Foss M, Bunger C, Besenbacher F, Soballe K,. Hydroxyapatite nanoparticles in poly-D,L-lactic acid coatings on porous titanium implants conducts bone formation. J Biomed Mater Res A 2010; 95: 665-672.
26. Baddeley AJ, Gundersen HJ, Cruz-Orive LM,. Estimation of surface area from vertical sections. J Microsc 1986; 142 (Pt 3): 259-276.
27. Baas J,. Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs. Acta Orthop Suppl 2008; 79: 1-43.
28. Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96: 379-394.
29. Noble PC, Alexander JW, Lindahl LJ, Yew DT, Granberry WM, Tullos HS,. The anatomic basis of femoral component design. Clin Orthop Relat Res 1988; 235: 148-165.
30. Schimmel JW, Huiskes R,. Primary fit of the Lord cement-less total hip. A geometric study in cadavers. Acta Orthop Scand 1988; 59: 638-642. (Pubitemid 19029685)
31. Kazanecki CC, Uzwiak DJ, Denhardt DT,. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 2007; 102: 912-924. (Pubitemid 350036931)
32. Razzouk S, Brunn JC, Qin C, Tye CE, Goldberg HA, Butler WT,. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone 2002; 30: 40-47. (Pubitemid 34044299)
33. Capriotti LA, Beebe TP, Jr. , Schneider JP,. Hydroxyapatite surface-induced peptide folding. J Am Chem Soc 2007; 129: 5281-5287. (Pubitemid 46651407)
34. Branemark R, Ohrnell LO, Nilsson P, Thomsen P,. Biomechanical characterization of osseointegration during healing: an experimental in vivo study in the rat. Biomaterials 1997; 18: 969-978. (Pubitemid 27296557)
35. Soballe K, Hansen ES, Brockstedt-Rasmussen H, Pedersen CM, Bunger C,. Hydroxyapatite coating enhances fixation of porous coated implants. A comparison in dogs between press fit and noninterference fit. Acta Orthop Scand 1990; 61: 299-306. (Pubitemid 20271339)
36. Mouzin O, Soballe K, Bechtold JE,. Loading improves anchorage of hydroxyapatite implants more than titanium implants. J Biomed Mater Res 2001; 58: 61-68. (Pubitemid 32150702)
37. Stromberg L, Dalen N,. The influence of freezing on the maximum torque capacity of long bones. An experimental study on dogs. Acta Orthop Scand 1976; 47: 254-256.
38. Lamberg A, Schmidmaier G, Soballe K, Elmengaard B,. Locally delivered TGF-beta1 and IGF-1 enhance the fixation of titanium implants: a study in dogs. Acta Orthop 2006; 77: 799-805. (Pubitemid 44521923)
39. Schmidmaier G, Wildemann B, Ostapowicz D, Kandziora F, Stange R, Haas NP, Raschke M,. Long-term effects of local growth factor (IGF-I and TGF-beta 1) treatment on fracture healing. A safety study for using growth factors. J Orthop Res 2004; 22: 514-519. (Pubitemid 38489727)
40. Wildemann B, Sander A, Schwabe P, Lucke M, Stockle U, Raschke M, Haas NP, Schmidmaier G,. Short term in vivo biocompatibility testing of biodegradable poly(D,L-lactide)-growth factor coating for orthopaedic implants. Biomaterials 2005; 26: 4035-4040. (Pubitemid 40038792)